Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.1K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

637
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
637

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-Compensatory Saccades Changes After Visuo-Vestibular Physical Therapy in People With Acute Unilateral Vestibulopathy: A Prospective Observational Study.

Physiotherapy research international : the journal for researchers and clinicians in physical therapy·2026
Same author

A Practice Framework for Genetic Testing in Asymptomatic Relatives of Patients With Creutzfeldt-Jakob Disease: Experience and Insights From Israel.

European journal of neurology·2026
Same author

Essential genetic testing in movement disorders - results from a Delphi study.

Parkinsonism & related disorders·2026
Same author

Recruitment Strategies across the Spectrum of Neuronal Synuclein Disease.

Annals of neurology·2026
Same author

The construct validity of real-world digital mobility outcomes in people with COPD.

ERJ open research·2026
Same author

Electroencephalography-Based Clustering Reveals Robust Neurophysiological Subtypes in Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026

Related Experiment Video

Updated: Nov 6, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.6K

Detecting Sensitive Mobility Features for Parkinson's Disease Stages Via Machine Learning.

Anat Mirelman1,2, Mor Ben Or Frank1, Michal Melamed3

  • 1Laboratory for Early Markers Of Neurodegeneration (LEMON), Center for the Study of Movement, Cognition and Mobility, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel.

Movement Disorders : Official Journal of the Movement Disorder Society
|May 6, 2021
PubMed
Summary
This summary is machine-generated.

Wearable sensors can track Parkinson's disease (PD) progression by identifying specific gait and mobility measures. Different sensor locations and gait metrics effectively distinguish early, mid, and advanced PD motor stages.

Keywords:
Parkinson's diseaseaccelerometergaitmachine learningwearables

More Related Videos

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.0K
Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
10:32

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Published on: June 17, 2013

55.8K

Related Experiment Videos

Last Updated: Nov 6, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.6K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.0K
Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
10:32

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Published on: June 17, 2013

55.8K

Area of Science:

  • Neurology
  • Biomedical Engineering
  • Data Science

Background:

  • Parkinson's disease (PD) severity assessment often relies on subjective clinical scales.
  • Objective gait and mobility measures are needed to track PD progression across its spectrum.
  • Current understanding of how specific gait parameters reflect PD stages is limited.

Purpose of the Study:

  • To identify sensitive gait and mobility measures for PD motor stages.
  • To determine optimal wearable sensor locations for different PD stages.
  • To utilize machine learning for objective PD assessment.

Main Methods:

  • Collected wearable sensor data from 332 PD patients (Hoehn and Yahr I-III) and 100 controls.
  • Utilized sensors on the lower back, ankles, and wrists during walking and dual-task conditions.
  • Applied machine learning algorithms for feature selection and classification.

Main Results:

  • Achieved high discrimination between PD motor stages (sensitivity 72%-83%, specificity 69%-80%, AUC 0.76-0.90).
  • Upper-limb sensors distinguished early PD from controls.
  • Trunk sensors identified turning measures in mid-stage PD.
  • Stride timing and regularity were key in advanced PD stages.

Conclusions:

  • Machine learning applied to wearable sensor data reveals distinct gait and mobility features for different PD stages.
  • These objective measures can enhance PD monitoring and clinical trial design.
  • Wearable technology offers a promising avenue for objective Parkinson's disease assessment.